JIANGSU HENGRUI PHARMACEUTICALS CO revenue breakdown overview

JIANGSU HENGRUI PHARMACEUTICALS CO revenue for the last year amounted to 22.82 B CNY, the most of which — 12.22 B CNY — came from its highest performing source at the moment, Anti-tumor, the year earlier bringing 11.31 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought JIANGSU HENGRUI PHARMACEUTICALS CO 21.76 B CNY, and the year before that — 20.43 B CNY.